Cargando...
Targeting WDR5: A WINning Anti-Cancer Strategy?
WDR5 is a component of multiple epigenetic regulatory complexes, including the mixed lineage leukemia (MLL)/SET complexes that deposit histone H3 lysine 4 methylation. Inhibitors of an arginine-binding cavity in WDR5, known as the WDR5-interaction (WIN) site, have been proposed to selectively kill M...
Gardado en:
| Publicado en: | Epigenet Insights |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6640055/ https://ncbi.nlm.nih.gov/pubmed/31360909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2516865719865282 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|